• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病患者中与疥疮相关的反应性穿通性胶原病。

Reactive perforating collagenosis associated with scabies in a diabetic.

作者信息

Brinkmeier T, Herbst R A, Frosch P J

机构信息

Department of Dermatology, Klinikum Dortmund gGmbH, and University of Witten/Herdecke, Beurhausstrasse 40, D-44137 Dortmund, Germany.

出版信息

J Eur Acad Dermatol Venereol. 2004 Sep;18(5):588-90. doi: 10.1111/j.1468-3083.2004.00978.x.

DOI:10.1111/j.1468-3083.2004.00978.x
PMID:15324402
Abstract

Reactive perforating collagenosis (RPC) in adults commonly manifests in patients with diabetes mellitus. Pruritus and consequent induced scratching have been identified as the bases for the evolution of this skin disease. We present the unusual case of a 55-year-old female diabetic with characteristic umbilicated skin lesions and a long history of scabies. Histology from a crusty nodule revealed transepidermal elimination of collagen. Following antiscabietic treatment, two courses of oral doxycycline demonstrated beneficial effects in controlling the perforating skin disorder.

摘要

成人反应性穿通性胶原病(RPC)常见于糖尿病患者。瘙痒及随之而来的搔抓已被确认为这种皮肤病演变的基础。我们报告了一例不寻常的病例,一名55岁的女性糖尿病患者,有典型的脐状皮肤病变且有长期疥疮病史。一个结痂结节的组织学检查显示有胶原的表皮穿通性消除。经过抗疥疮治疗后,两个疗程的口服多西环素在控制这种穿通性皮肤病方面显示出有益效果。

相似文献

1
Reactive perforating collagenosis associated with scabies in a diabetic.糖尿病患者中与疥疮相关的反应性穿通性胶原病。
J Eur Acad Dermatol Venereol. 2004 Sep;18(5):588-90. doi: 10.1111/j.1468-3083.2004.00978.x.
2
Acquired reactive perforating collagenosis in a diabetic patient with pulmonary aspergillosis.一名患有肺曲霉病的糖尿病患者发生获得性反应性穿通性胶原病。
Cutis. 2000 Dec;66(6):425-30.
3
Scabies-induced acquired reactive perforating collagenosis.
J Eur Acad Dermatol Venereol. 2008 Jan;22(1):120-1. doi: 10.1111/j.1468-3083.2007.02285.x.
4
Treatment of pruritus of reactive perforating collagenosis using transcutaneous electrical nerve stimulation.经皮电刺激神经治疗反应性穿通性胶原病瘙痒症
Eur J Dermatol. 2000 Jan-Feb;10(1):59-61.
5
Acquired reactive perforating collagenosis in an insulin dependent diabetes mellitus patient.一名胰岛素依赖型糖尿病患者的获得性反应性穿通性胶原病
J Indian Med Assoc. 2009 Nov;107(11):825-6.
6
Acquired reactive perforating collagenosis: four patients with a giant variant treated with allopurinol.获得性反应性穿通性胶原病:4例巨变型患者接受别嘌醇治疗。
Br J Dermatol. 2006 Apr;154(4):759-62. doi: 10.1111/j.1365-2133.2005.07111.x.
7
Gangrenous staphylococcal infections localized on the lesions of acquired reactive perforating collagenosis.坏疽性葡萄球菌感染局限于获得性反应性穿通性胶原病的病变部位。
J Dermatol. 2008 Sep;35(9):594-7. doi: 10.1111/j.1346-8138.2008.00529.x.
8
Perforating collagenosis.
Dermatol Online J. 2008 Oct 15;14(10):14.
9
Acquired reactive perforating collagenosis.获得性反应性穿通性胶原病
Eur J Dermatol. 2001 Sep-Oct;11(5):466-8.
10
Reactive perforating collagenosis of diabetes mellitus and renal failure.糖尿病合并肾衰竭的反应性穿通性胶原病
Cutis. 1983 Jan;31(1):55-8.

引用本文的文献

1
Acquired Perforating Dermatosis: Clinical and Histopathological Analysis of 95 Patients From One Center.获得性穿通性皮肤病:来自一个中心的95例患者的临床和组织病理学分析。
Dermatol Pract Concept. 2024 Apr 1;14(2):e2024100. doi: 10.5826/dpc.1402a100.
2
Dupilumab improve acquired reactive perforating collagenosis characterized by type 2 inflammation.度普利尤单抗可改善由 2 型炎症引起的获得性反应性穿孔性胶原病。
Front Immunol. 2023 Aug 10;14:1240262. doi: 10.3389/fimmu.2023.1240262. eCollection 2023.
3
Acquired reactive perforating collagenosis.
获得性反应性穿通性胶原病
Eurasian J Med. 2012 Apr;44(1):51-3. doi: 10.5152/eajm.2012.11.
4
[Acquired reactive perforating collagenosis following herpes zoster as isotopic response?].[带状疱疹后获得性反应性穿通性胶原病作为同位素反应?]
Hautarzt. 2011 Sep;62(9):683-7. doi: 10.1007/s00105-011-2202-1.
5
[Reactive perforating collagenosis disease].[反应性穿通性胶原病]
Hautarzt. 2005 Oct;56(10):963-5. doi: 10.1007/s00105-005-1023-5.